PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
17540440-0	2007	The 5-HT3 receptor partial agonist MD-354 (meta-chlorophenylguanidine) enhances the discriminative stimulus actions of (+)amphetamine in rats.	Amphetamine	119-133	5-hydroxytryptamine receptor 3A	Rattus norvegicus	4-18	
17540440-1	2007	The effect of the 5-HT3 receptor partial agonist MD-354 (meta-chlorophenylguanidine) was examined on the discriminative stimulus produced by (+)amphetamine.	Amphetamine	141-155	5-hydroxytryptamine receptor 3A	Rattus norvegicus	18-32	
10941627-0	2000	Effect of the 5-HT3 receptor antagonist ondansetron on amphetamine-induced hyperactivity and stereotypy in rats.	Amphetamine	55-66	5-hydroxytryptamine receptor 3A	Rattus norvegicus	14-28	
9704883-0	1998	5-HT3 receptor activation is required for induction of striatal c-Fos and phosphorylation of ATF-1 by amphetamine.	Amphetamine	102-113	5-hydroxytryptamine receptor 3A	Rattus norvegicus	0-14	
9838105-10	1998	These findings demonstrate that the 5-HT3R antagonist, MDL 72222, can positively modulate morphine-induced IEG expression in the rat CPu in a dose dependent manner, in contrast to the reported suppressive effect observed when this antagonist is administered prior to amphetamine.	Amphetamine	267-278	5-hydroxytryptamine receptor 3A	Rattus norvegicus	36-42	
9704883-7	1998	Furthermore, amphetamine-induced striatal c-Fos was completely inhibited by administration of the 5-HT3 receptor antagonist, MDL-72222, but not by the 5-HT2A/2C receptor antagonist, ritanserin.	Amphetamine	13-24	5-hydroxytryptamine receptor 3A	Rattus norvegicus	98-112	
9704883-10	1998	These results suggest that 5-HT3 receptor activation may be required for amphetamine-induced expression of ATF-1-regulated target genes in the striatum, which may include c-Fos.	Amphetamine	73-84	5-hydroxytryptamine receptor 3A	Rattus norvegicus	27-41	
8737967-0	1996	5-HT3 receptor antagonist MDL 72222 dose-dependently attenuates cocaine- and amphetamine-induced elevations of extracellular dopamine in the nucleus accumbens and the dorsal striatum.	Amphetamine	77-88	5-hydroxytryptamine receptor 3A	Rattus norvegicus	0-14	
8737967-7	1996	The different potencies of the interactions of the 5-HT3 receptor antagonist with cocaine and amphetamine could be related to the different mechanisms by which these drugs primarily elevate extracellular dopamine.	Amphetamine	94-105	5-hydroxytryptamine receptor 3A	Rattus norvegicus	51-65	
7855229-4	1994	Ondansetron, a selective and potent 5HT3 receptor antagonist, was also shown to be effective at blocking the amphetamine-induced disruption of LI at a dose of 0.01 mg/kg, but not at 0.1 mg/kg.	Amphetamine	109-120	5-hydroxytryptamine receptor 3A	Rattus norvegicus	36-49	
1534768-0	1992	The effect of 5-HT3 receptor antagonists on the discriminative stimulus effects of amphetamine.	Amphetamine	83-94	5-hydroxytryptamine receptor 3A	Rattus norvegicus	14-28	
2203069-2	1990	5-HT3 receptor antagonists GR38032F, zacopride, ICS 205-930 and other agents are very potent in reducing mesolimbic dopamine hyperactivity caused by the injection of amphetamine or infusion of dopamine into the rat nucleus accumbens and amygdala, and the ventral striatum of the marmoset.	Amphetamine	166-177	5-hydroxytryptamine receptor 3A	Rattus norvegicus	0-14